Investigating the contribution of VAPB/ALS8 loss of function in amyotrophic lateral sclerosis
Page 1 of 1
Investigating the contribution of VAPB/ALS8 loss of function in amyotrophic lateral sclerosis
Jon Moulton Mon Mar 04, 2013 12:08 pm
Kabashi E, El Oussini H, Bercier V, Gros-Louis F, Valdmanis PN, McDearmid J, Mejier IA, Dion PA, Dupre N, Hollinger D, Sinniger J, Dirrig-Grosch S, Camu W, Meininger V, Loeffler JP, René F, Drapeau P, Rouleau GA, Dupuis L. Investigating the contribution of VAPB/ALS8 loss of function in amyotrophic lateral sclerosis. Hum Mol Genet. 2013 Feb 26. [Epub ahead of print]
Jon Moulton- Posts : 5721
Join date : 2010-03-12
Age : 61
Location : Philomath, Oregon, USA -
Similar topics» Loss of function of C9orf72 causes motor deficits in a zebrafish model of Amyotrophic Lateral Sclerosis
» FUS and TARDBP but Not SOD1 Interact in Genetic Models of Amyotrophic Lateral Sclerosis
» EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans
» Morpholino-mediated SOD1 reduction ameliorates an amyotrophic lateral sclerosis disease phenotype
» Deleterious mutations in the essential mRNA metabolism factor, hGle1, in Amyotrophic Lateral Sclerosis
» FUS and TARDBP but Not SOD1 Interact in Genetic Models of Amyotrophic Lateral Sclerosis
» EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans
» Morpholino-mediated SOD1 reduction ameliorates an amyotrophic lateral sclerosis disease phenotype
» Deleterious mutations in the essential mRNA metabolism factor, hGle1, in Amyotrophic Lateral Sclerosis
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum|
|
|